Sofía Ballesta

Sofía Ballesta

Auto-generated profile, based on publicly available information

Sofía Ballesta

Department of Microbiology, School of Medicine, University of Seville, Seville, Spain

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2014 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
MAMatteo Albertini
Matteo Albertini
LLLorena López-Cerero
Lorena López-Cerero
MOManuel G. O'Sullivan
Manuel G. O'Sullivan
CCCarlos F. Chereguini
Carlos F. Chereguini
SBSofia Ballesta
Sofia Ballesta
PBPedro Bullon
Pedro Bullon

27 March 2015 in Future Microbiology
Verified
Journal Article
Closed access
IGIsabel García
Isabel García
SBSofía Ballesta
Sofía Ballesta
Yolanda GilaberteYolanda Gilaberte
Yolanda Gilaberte
ALAntonio Rezusta López
Antonio Rezusta López
ÁPÁlvaro Pascual
Álvaro Pascual
To evaluate the effectiveness of the photodynamic therapy using hypericin (HYP) against both planktonic and biofilm-forming Staphylococcus aureus. HYP photoactivity was evaluated against methicillin-susceptible and resistant S. aureus. Bacterial suspension or biofilm were preincubated with HYP and subjected to LED illumination. Viable bacteria were determined by colony counting. Preincubation with HYP (5 min) plus light exposure (10 min) showed bactericidal effect against planktonic methicillin-susceptible S. aureus and methicillin-resistant S. aureus. Longer preincubation times (24 h) and time light exposure (30 min) were required to reach HYP-photoactivity against S. aureus biofilms. HYP-photoactivity was correlated to the biofilm production. HYP could be a potential photosensitizer for the inactivation of staphylococcal biofilms forming on the surfaces accessible to visible light.

1 September 2000 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
LMLuis Martínez Martínez
Luis Martínez Martínez
MCM. C. Conejo
M. C. Conejo
APA. Pascual
A. Pascual
SHS. Hernández-Allés
S. Hernández-Allés
SBS. Ballesta
S. Ballesta
EPE. J. Perea
E. J. Perea
Forty clonally related clinical isolates of Escherichia coli from hospitalized patients were resistant to cefoxitin (MICs, >256 μg/ml) and ceftazidime (MICs, 32 to 256 μg/ml) and were intermediate or resistant to cefotaxime (MICs, 16 to 128 μg/ml) but susceptible to both cefepime (MICs, 0.5 to 2 μg/ml) and imipenem (MICs, 0.125 to 0.25 μg/ml). Resistance to β-lactams was related to high-level production of AmpC β-lactamase and loss of OmpF porin.

1 October 2007 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
JRJosé Manuel Rodríguez-Martínez
José Manuel Rodríguez-Martínez
SBSofía Ballesta
Sofía Ballesta
ÁPÁlvaro Pascual
Álvaro Pascual

1 March 2018 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
VPVanesa Pérez-Laguna
Vanesa Pérez-Laguna
IGIsabel García-Luque
Isabel García-Luque
SBSofía Ballesta
Sofía Ballesta
LPLuna Pérez-Artiaga
Luna Pérez-Artiaga
VLVerónica Lampaya-Pérez
Verónica Lampaya-Pérez
Yolanda GilaberteYolanda Gilaberte
Yolanda Gilaberte

1 January 1999 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
APAlvaro Pascual
Alvaro Pascual
IGIsabel García
Isabel García
SBSofía Ballesta
Sofía Ballesta
EPEvelio J. Perea
Evelio J. Perea
The penetration by moxifloxacin of human neutrophils (polymorphonuclear leukocytes [PMN]) and tissue-cultured epithelial cells (McCoy cells) was evaluated by a fluorometric assay. At extracellular concentrations of 5 mg/liter, the cellular-to-extracellular concentration ratios (C/E) of moxifloxacin in PMN and McCoy cells were 10.9 ± 1.0 and 8.7 ± 1.0, respectively (20 min; 37°C). The uptake of moxifloxacin by PMN was rapid, reversible, nonsaturable (at extracellular concentrations ranging from 1 to 50 μg/ml), and not affected by cell viability. The uptake of moxifloxacin was affected by external pH and the environmental temperature. The incubation of PMN in the presence of sodium fluoride, sodium cyanide, and carbonyl cyanide m -chlorophenylhydrazone significantly decreased the C/E of this agent. Neither PMN stimulation nor phagocytosis of opsonized Staphylococcus aureus significantly affected the uptake of moxifloxacin by human PMN. This agent, at concentrations of 0.5, 1, and 5 mg/liter, induced a significant reduction in the survival of intracellular S. aureus in human PMN. In summary, moxifloxacin reaches much higher intracellular concentrations within phagocytic and nonphagocytic cells than extracellular ones, remaining active inside the neutrophils.